Losartan Potassium we care

Losartan Potassium we care

losartan

Manufacturer:

Mega Lifesciences

Distributor:

Maxxcare
Concise Prescribing Info
Contents
Losartan K
Dosage/Direction for Use
Usual start & maintenance dose: 50 mg once daily, may be increased to 100 mg once daily. Patient w/ intravascular vol-depletion Initially 25 mg once daily.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Discontinue if pregnancy is suspected; do not use during pregnancy & lactation. Childn.
Special Precautions
Patients w/ bilateral renal artery, single kidney artery & aortic valve stenosis, & hypertrophic obstructive cardiomyopathy. Symptomatic hypotension may occur after initiation of therapy. Hepatic (consider dose reduction) & renal impairment. Hypotension in patients w/ vol-depletion (eg, under high-dose diuretic therapy). Hyperkalemia may occur; monitor serum K conc in elderly patients. Potential oliguria &/or progressive azotemia (less frequent) w/ acute renal failure &/or death in patients whose renal function may be renin-angiotensin-aldosterone-system-dependent (eg, patients w/ severe CHF).
Adverse Reactions
Headache.
Drug Interactions
Antihypertensive effect may be antagonised by NSAIDs. Potential reduced antihypertensive effect in concurrent use w/ sympathomimetics. Potential hyperkalemia in concurrent use w/ K-sparing diuretics, K-containing medication or K supplements.
MIMS Class
Angiotensin II Antagonists
ATC Classification
C09CA01 - losartan ; Belongs to the class of angiotensin II receptor blockers (ARBs). Used in the treatment of cardiovascular disease.
Presentation/Packing
Form
Losartan Potassium we care FC tab 25 mg
Packing/Price
10 × 10's
Form
Losartan Potassium we care FC tab 50 mg
Packing/Price
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in